Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hunt

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|January 12, 2011
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected womenRobert C Kaplan, Elizabeth Sinclair, Alan L Landay, et al.
The Journal of Infectious Diseases|March 7, 2009
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infectionWei Jiang, Michael M Lederman, Peter Hunt, et al.
Blood|May 1, 2004
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral loadSteven G Deeks, Christina M R Kitchen, Lea Liu, et al.
The Journal of Infectious Diseases|March 7, 2023
Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral TherapyElizabeth Hastie, Carlee Moser, Xin Sun, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary aminesThomas Hunt, Hazel C Atherton-Watson, Jake Axford, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonistsDavid W Porter, Michelle Bradley, Zarin Brown, et al.
Nature|April 19, 2011
Differential microRNA regulation of HLA-C expression and its association with HIV controlSmita Kulkarni, Ram Savan, Ying Qi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2013
Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010Elizabeth L Yanik, Sonia Napravnik, Patrick Ryscavage, et al.
AIDS (London, England)|April 1, 2014
Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidenceElizabeth L Yanik, Sonia Napravnik, Stephen R Cole, et al.
AIDS (London, England)|March 25, 2025
Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIVMaria J Duarte, Phyllis C Tien, Ani Kardashian, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|January 12, 2011
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected womenRobert C Kaplan, Elizabeth Sinclair, Alan L Landay, et al.
The Journal of Infectious Diseases|March 7, 2009
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infectionWei Jiang, Michael M Lederman, Peter Hunt, et al.
Blood|May 1, 2004
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral loadSteven G Deeks, Christina M R Kitchen, Lea Liu, et al.
The Journal of Infectious Diseases|March 7, 2023
Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral TherapyElizabeth Hastie, Carlee Moser, Xin Sun, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary aminesThomas Hunt, Hazel C Atherton-Watson, Jake Axford, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonistsDavid W Porter, Michelle Bradley, Zarin Brown, et al.
Nature|April 19, 2011
Differential microRNA regulation of HLA-C expression and its association with HIV controlSmita Kulkarni, Ram Savan, Ying Qi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2013
Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010Elizabeth L Yanik, Sonia Napravnik, Patrick Ryscavage, et al.
AIDS (London, England)|April 1, 2014
Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidenceElizabeth L Yanik, Sonia Napravnik, Stephen R Cole, et al.
AIDS (London, England)|March 25, 2025
Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIVMaria J Duarte, Phyllis C Tien, Ani Kardashian, et al.
Pageof 9